Cutler Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-600
| Closed | -$10K | – | 2055 |
|
|
2021
Q2 | $10K | Sell |
600
-2,300
| -79% | -$38.3K | ﹤0.01% | 1706 |
|
|
2021
Q1 | $73K | Sell |
2,900
-700
| -19% | -$17.6K | ﹤0.01% | 1009 |
|
|
2020
Q4 | $23K | Hold |
3,600
| – | – | ﹤0.01% | 1232 |
|
|
2020
Q3 | $9K | Buy |
3,600
+200
| +6% | +$500 | ﹤0.01% | 1324 |
|
|
2020
Q2 | $5K | Hold |
3,400
| – | – | ﹤0.01% | 1319 |
|
|
2020
Q1 | $3K | Hold |
3,400
| – | – | ﹤0.01% | 1255 |
|
|
2019
Q4 | $6K | Sell |
3,400
-3,100
| -48% | -$5.47K | ﹤0.01% | 1295 |
|
|
2019
Q3 | $7K | Sell |
6,500
-2,900
| -31% | -$3.12K | ﹤0.01% | 1236 |
|
|
2019
Q2 | $20K | Buy |
9,400
+9,100
| +3,033% | +$19.4K | ﹤0.01% | 1149 |
|
|
2019
Q1 | $1K | Sell |
300
-100
| -25% | -$333 | ﹤0.01% | 1406 |
|
|
2018
Q4 | $2K | Buy |
+400
| New | +$2K | ﹤0.01% | 1457 |
|
|
2018
Q3 | – | Sell |
-200
| Closed | -$3K | – | 1574 |
|
|
2018
Q2 | $3K | Sell |
200
-300
| -60% | -$4.5K | ﹤0.01% | 1496 |
|
|
2018
Q1 | $8K | Sell |
500
-300
| -38% | -$4.8K | ﹤0.01% | 1444 |
|
|
2017
Q4 | $19K | Buy |
800
+700
| +700% | +$16.6K | ﹤0.01% | 1400 |
|
|
2017
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 2274 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 2705 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 2736 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 2793 |
|